Table 2.
Mean values (± SD) recorded in the three groups of cats
Controls (C) (n=24) | FCoV-exposed (FE) (n=11) | FIP(F) (n=32) | ANOVA | Tukey HSD test |
Reference values | |||
---|---|---|---|---|---|---|---|---|
* | ** | *** | ||||||
Total proteins (g/dL) | 7.69±0.83 | 7.86±0.67 | 8.27±1.49 | n.s. | 5.4–7.8a | |||
A/G ratio | 1.03±0.24 | 0.97±0.32 | 0.47±0.25 | *** | F vs. C,FE | 0.45–1.19a | ||
Albumins (g/dL) | 3.83±0.57 | 3.91±0.99 | 2.43±0.46 | *** | F vs. C, FE | 2.1–3.3a | ||
Globulins (g/dL) | 3.86±0.74 | 4.29±1.21 | 5.85±1.57 | *** | F vs. FE | F vs. C | 2.6–5.1a | |
α1-Globulins (g/dL) | 0.55±0.34 | 0.64±0.26 | 0.53±0.28 | n.s. | 0.2–1.1a | |||
α2-Globulins (g/dL) | 0.71±0.33 | 0.54±0.21 | 1.16±0.43 | *** | F vs. C, FE | 0.4–0.9a | ||
β-Globulins (g/dL) | 0.76±0.18 | 0.82±0.39 | 1.09±0.51 | ** | F vs. C | 0.9–1.9a | ||
γ-Globulins (g/dL) | 1.84±0.57 | 2.29±0.87 | 3.07±1.41 | *** | F vs. C | 2.5–4.1b | ||
Serum amyloid A (μg/mL) | 10.21±8.32 (n=17) | 7.92±7.12 (n=7) | 82.88±50.23 (n=26) | *** | F vs. C, FE | 16.6±11.4c | ||
Haptoglobin (mg/mL) | 1.30±0.64 | 1.80±0.83 | 2.13±0.73 | *** | F vs. FE | F vs. C | 0.04–3.84d | |
α1-Acid glycoprotein (mg/mL) | 1.20±0.62 (n=22) | 1.19±0.49 (n=11) | 2.72±1.46 (n=29) | *** | F vs. C, FE | 0.1–0.48d | ||
Immunoglobulin G (g/dL) | 1.73±1.8 (n=7) | n.d. | 2.25±3.09 (n=30) | n.s. | 0.4–2.00e | |||
Immunoglobulin M (g/dL) | 0.63±0.63 (n=7) | n.d. | 0.36±0.31 (n=30) | n.s. | 0.03–0.15e |
*P<0.05; **P<0.01; ***P<0.001; n.d.=not determined; n.s.=not significant.
From Kaneko (1997).
From Kajikawa et al. (1999).
From Duthie et al. (1997).
From Tizard (2000).